How Pharmacists Are Expanding HIV PrEP And PEP Access
HIV prevention is becoming more accessible, practical and routine, with pharmacists playing a growing role in education, referral, medication supply and ongoing support. Pre-exposure prophylaxis, commonly called PrEP, can substantially reduce the risk of HIV when taken as prescribed. Post-exposure prophylaxis, or PEP, is an urgent 28-day course used after a possible exposure and works best when started as soon as possible.
For people in Australia, the local pharmacy is often easier to reach than a specialist clinic. Community pharmacists are available in metropolitan suburbs, regional towns and many shopping centres, usually without an appointment. Their regular contact with patients places them in a strong position to explain HIV prevention, reduce stigma and help people navigate testing, prescriptions and follow-up care.
Why PrEP And PEP Need Pharmacy Support
PrEP and PEP involve more than handing over tablets. People need clear information about how the medicines work, when they should be taken, what testing is required and which symptoms should prompt medical attention. They may also need help understanding the difference between daily PrEP, event-based dosing where clinically appropriate, and PEP after a recent exposure.
Pharmacists can provide a calm, private first conversation for someone who is unsure where to begin. A person may be concerned about confidentiality, judgement, cost or whether their circumstances “qualify” for prevention. An informed pharmacist can explain that HIV prevention is relevant to a wide range of people, including those with partners of unknown HIV status, people experiencing condom failure and people whose sexual or injecting circumstances have changed.
The pharmacy also provides an important safety net. A pharmacist who recognises a time-critical PEP request can direct the person to an emergency department, sexual health service or authorised prescriber without unnecessary delay. PEP is not a medicine to place on a routine repeat schedule; the exposure history, timing, baseline testing and medical suitability need prompt assessment.
From Information To Risk Assessment
Good counselling begins with open, neutral language. Pharmacists do not need to ask intrusive questions, but they do need enough information to identify urgency and direct the person to appropriate care. Useful topics include when the possible exposure occurred, the type of contact, whether a condom was used, whether the other person is known to have HIV, and whether the person has taken PrEP before.
PrEP users require regular HIV testing and clinical review. Depending on the regimen and individual circumstances, clinicians may monitor kidney function, hepatitis status, sexually transmitted infections and medication adherence. Pharmacists can reinforce these requirements, check whether follow-up appointments have been booked and identify barriers such as shift work, transport, unstable housing or difficulty paying for medicines.
The conversation should include prevention beyond HIV. Condoms, vaccinations, STI screening, hepatitis care, overdose prevention and mental health support may all be relevant. Referral does not mean a pharmacist has failed to help; it means the patient is being connected with the right part of the health system while receiving practical support at the point of need.
Making Access Work Across Australia
Australia has a mixed geography and healthcare landscape. Someone in inner Melbourne or Sydney may have several sexual health clinics nearby, while a person in a remote Northern Territory community may face long travel distances, limited appointment availability and concerns about privacy. Pharmacies in regional Queensland, Western Australia and New South Wales can help bridge these gaps by explaining options and coordinating referrals.
PrEP has been available through the Pharmaceutical Benefits Scheme for eligible patients since 2018, although access still depends on a valid prescription and the applicable PBS arrangements. Private supply and sexual health services may be important alternatives for people who are not eligible or who need an immediate pathway. Pharmacists can explain likely costs without assuming that every patient understands PBS co-payments, concession arrangements or prescription validity.
Legislation and pharmacist prescribing authority vary between Australian states and territories and continue to develop. Some jurisdictions have expanded pharmacist-led services or prescribing pilots, while others require PrEP and PEP to be prescribed by a doctor or authorised nurse practitioner. Pharmacy teams should follow current state or territory rules, professional standards and local clinical protocols rather than treating a national approach as uniform.
Aboriginal and Torres Strait Islander communities also need services that are culturally safe and locally appropriate. Working with Aboriginal Community Controlled Health Services, sexual health nurses and community leaders can improve trust and continuity. A standardised script alone cannot address the effects of stigma, racism, language barriers or previous negative healthcare experiences.
Safe Dispensing And Follow-Up
Dispensing PrEP requires attention to the complete medication picture. Pharmacists should check allergies, renal risk, hepatitis B status where relevant, interactions and the intended dosing schedule. They should also confirm that the patient understands what to do after a missed dose and when to seek advice. Written information can support the discussion, particularly when a patient is anxious or collecting the medicine in a busy environment.
Confidentiality is central. Conversations should take place away from the main counter, records should be handled carefully and staff should avoid announcing the medicine name where others can hear. These principles are familiar from other sensitive medicines and controlled substances; a useful professional reference is this discussion of ethical dispensing, which highlights the balance between patient care, privacy and legal duties.
Continuity matters just as much as the first supply. A pharmacist can offer a reminder for the next collection, check adherence without blame and ask whether the person has experienced side effects or difficulty taking tablets. If a patient repeatedly misses clinical reviews, the pharmacy can encourage contact with the prescriber or sexual health service rather than simply supplying medication without the required monitoring.
PEP creates a different workflow because time is critical. Pharmacy staff should know which local hospital, sexual health clinic or after-hours service can assess a patient immediately. Emergency preparedness principles used during wider public health disruptions can inform this process; guidance on prescription continuity offers relevant lessons about supply planning, documentation and communication when ordinary pathways are interrupted.
Telehealth, Privacy, And Digital Reach
Telehealth has increased the range of clinicians available to people who cannot easily attend a clinic. It can be particularly useful for PrEP reviews, repeat prescriptions and follow-up testing, provided the patient has access to pathology, a private place to speak and a reliable way to collect medication. Pharmacists can help patients understand how a telehealth prescription will reach the pharmacy and what identification or electronic prescription processes may apply.
The wider impact of telemedicine also raises practical questions about continuity and responsibility. A virtual consultation should still connect the patient with testing, results review and a clear plan for adverse effects. Pharmacists are often the professionals who notice when a telehealth arrangement has produced confusion, an incomplete prescription or no obvious follow-up pathway.
Digital access must not become a new exclusion. Some patients share phones, have limited data, lack stable internet or do not feel safe storing health information electronically. Pharmacies can offer printed instructions, phone-based reminders and referral details in accessible formats. Staff should avoid assuming that a person who appears confident online understands HIV prevention or feels comfortable discussing it digitally.
Education That Builds Trust
Community education works best when it is factual and free from alarm. Pharmacists can explain that PrEP prevents HIV but does not prevent other STIs, and that it does not replace testing or sexual health review. They can also clarify that PEP must be started quickly after a possible exposure and is different from taking PrEP in advance.
Language choices influence whether someone returns for care. Terms such as “risk behaviour” may sound judgemental, while “possible exposure” is more neutral and clinically useful. Inclusive communication should recognise heterosexual, gay, bisexual, queer and transgender people, as well as people who inject drugs and people whose partners are living with HIV. People living with HIV who have an undetectable viral load do not transmit HIV sexually, and accurate education can help reduce fear and stigma.
Pharmacists can use posters, private booking systems, staff training and partnerships with local sexual health organisations to make prevention visible without singling out individuals. Training should cover confidentiality, culturally safe care, gender-affirming communication and how to respond when a patient discloses coercion, violence or distress.
Practical Points For Pharmacy Teams
A consistent process helps staff respond confidently, even when the pharmacy is busy. It can be built into standard operating procedures and reviewed with nearby prescribers, laboratories, sexual health clinics and hospital services.
For PrEP conversations:
- Confirm whether the person has a current prescription and clinical follow-up plan.
- Check adherence, side effects, interactions and any change in health circumstances.
- Encourage recommended HIV, STI, renal and hepatitis monitoring.
- Provide a private, respectful discussion and clear written instructions.
For possible PEP requests:
- Ask when the possible exposure occurred and treat the request as time-sensitive.
- Direct the person promptly to an authorised PEP provider, emergency department or sexual health clinic.
- Avoid delaying referral while attempting to complete a routine dispensing assessment.
- Document advice and referral according to privacy, professional and local legal requirements.
Pharmacy owners and managers can support this work by identifying a private consultation area, training all team members and keeping current referral contacts beside the dispensary workflow. Stock and supply issues should be monitored, particularly in smaller communities where an unavailable medicine can create a significant delay.
The value of the pharmacist lies in combining accessibility with clinical boundaries. Pharmacists can educate, dispense when authorised, identify urgent needs, support adherence and coordinate care. They should also recognise when a person needs a prescriber, laboratory testing, specialist assessment or emergency treatment.
Expanding HIV PrEP and PEP education and access will depend on strong collaboration across community pharmacies, general practice, Aboriginal health services, sexual health clinics, hospitals and public health programs. When every part of that network understands its role, patients are less likely to be lost between an online consultation, a prescription and a pharmacy counter.
Pharmacy teams can begin by reviewing their local PEP pathway, training staff in inclusive conversations and creating a discreet process for PrEP counselling. Small operational changes can make prevention faster, safer and more welcoming for people across Australia.